FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Precigen BLA for Respiratory Papillomatosis Therapy

FDA accepts for priority review a Precigen BLA for PRGN-2012 (zopapogene imadenovec), an investigational adenoverse gene therapy for treating adults w...

latest-news-card-1
Biologics

Fertility Center of California HCT/P Deviations

FDA warns San Diego, CA-based Fertility Center of California about deviations from regulations governing cells, tissues, and cellular and tissue-based...

latest-news-card-1
Human Drugs

Priority Review for Keytruda Head/Neck Cancer sBLA

FDA accepts for priority review a Merck supplemental BLA for Keytruda (pembrolizumab) for treating patients with resectable locally advanced head and ...

latest-news-card-1
Human Drugs

FDA Removes Clozapine REMS Program

FDA removes a required risk evaluation and mitigation strategies program for clozapine and its requirement to report results of absolute neutrophil co...

latest-news-card-1
Human Drugs

4 Observations on AstraZeneca FDA-483

FDA releases the form FDA-483 issued following an inspection at the AstraZeneca Frederick, MD, drug manufacturing facility.

latest-news-card-1
Human Drugs

Emalex Ecopipam Meets Tourette Study Endpoints

Emalex Biosciences says it will meet with FDA to discuss submitting an NDA for its ecopipam to treat Tourette syndrome following successful results fr...

latest-news-card-1
Medical Devices

Tandem Diabetes Insulin Algorithm Cleared for Type 2

FDA clears Tandem Diabetes Cares next-generation automated insulin delivery algorithm, Control-IQ+ technology, for use in people with Type 2 diabetes....

latest-news-card-1
Human Drugs

Contaminated SinuCleanse Nasal Wash Recalled

Ascent Consumer Products recalls one lot of its SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System following a confirmed test result of microbial c...

Biologics

Invivyd EUA Request to Expand Covid Therapy Denied

FDA rejects an Invivyd request to expand the existing emergency use authorization for pre-exposure prophylaxis of Covid-19 EUA for Pemgarda (pemivibar...

latest-news-card-1
Human Drugs

Entrada Clinical Hold Lifted on Duchenne Drug

FDA lifts a 12/2022-ordered clinical hold on Entrada Therapeutics Duchenne muscular dystrophy therapy ENTR-601-44 and provided authorization to begin ...